Literature DB >> 10466411

Renal-coloboma syndrome: a multi-system developmental disorder caused by PAX2 mutations.

M R Eccles1, L A Schimmenti.   

Abstract

Optic nerve coloboma combined with renal disease, also called renal-coloboma syndrome ( # 120330 in McKusick's Mendelian Inheritance in Man Online, OMIM), a relatively recently characterized syndrome, results from autosomal dominant mutations in the PAX2 gene. Although renal-coloboma syndrome involves both ocular and renal anomalies, some patients are affected with vesico-ureteral reflux (VUR), high frequency hearing loss, central nervous system (CNS) anomalies, and/or genital anomalies, consistent with the expression of PAX2 in these tissues during development. We review here the clinical features of patients with renal-coloboma syndrome and PAX2 mutation. We also review the PAX2 mutations that have been reported to date, and discuss the possible effect of PAX2 mutations on normal development.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10466411     DOI: 10.1034/j.1399-0004.1999.560101.x

Source DB:  PubMed          Journal:  Clin Genet        ISSN: 0009-9163            Impact factor:   4.438


  44 in total

1.  Joint loss of PAX2 and PTEN expression in endometrial precancers and cancer.

Authors:  Nicolas M Monte; Kaitlyn A Webster; Donna Neuberg; Gregory R Dressler; George L Mutter
Journal:  Cancer Res       Date:  2010-07-14       Impact factor: 12.701

Review 2.  Neural crest derivatives in ocular development: discerning the eye of the storm.

Authors:  Antionette L Williams; Brenda L Bohnsack
Journal:  Birth Defects Res C Embryo Today       Date:  2015-06-04

Review 3.  Ocular coloboma: a reassessment in the age of molecular neuroscience.

Authors:  C Y Gregory-Evans; M J Williams; S Halford; K Gregory-Evans
Journal:  J Med Genet       Date:  2004-12       Impact factor: 6.318

4.  Expression profiling during ocular development identifies 2 Nlz genes with a critical role in optic fissure closure.

Authors:  Jacob D Brown; Sunit Dutta; Kapil Bharti; Robert F Bonner; Peter J Munson; Igor B Dawid; Amana L Akhtar; Ighovie F Onojafe; Ramakrishna P Alur; Jeffrey M Gross; J Fielding Hejtmancik; Xiaodong Jiao; Wai-Yee Chan; Brian P Brooks
Journal:  Proc Natl Acad Sci U S A       Date:  2009-01-26       Impact factor: 11.205

Review 5.  Transcriptional networks in the human epididymis.

Authors:  J A Browne; S-H Leir; S Yin; A Harris
Journal:  Andrology       Date:  2019-05-02       Impact factor: 3.842

6.  Severe prenatal renal anomalies associated with mutations in HNF1B or PAX2 genes.

Authors:  Leire Madariaga; Vincent Morinière; Cécile Jeanpierre; Raymonde Bouvier; Philippe Loget; Jelena Martinovic; Pierre Dechelotte; Nathalie Leporrier; Christel Thauvin-Robinet; Uffe Birk Jensen; Dominique Gaillard; Michele Mathieu; Bruno Turlin; Tania Attie-Bitach; Rémi Salomon; Marie-Claire Gübler; Corinne Antignac; Laurence Heidet
Journal:  Clin J Am Soc Nephrol       Date:  2013-03-28       Impact factor: 8.237

7.  Renal hypodysplasia associates with a WNT4 variant that causes aberrant canonical WNT signaling.

Authors:  Asaf Vivante; Michal Mark-Danieli; Miriam Davidovits; Orit Harari-Steinberg; Dorit Omer; Yehudit Gnatek; Roxana Cleper; Daniel Landau; Yael Kovalski; Irit Weissman; Israel Eisenstein; Michalle Soudack; Haike Reznik Wolf; Naomi Issler; Danny Lotan; Yair Anikster; Benjamin Dekel
Journal:  J Am Soc Nephrol       Date:  2013-03-21       Impact factor: 10.121

8.  Papillorenal syndrome-causing missense mutations in PAX2/Pax2 result in hypomorphic alleles in mouse and human.

Authors:  Ramakrishna P Alur; Camasamudram Vijayasarathy; Jacob D Brown; Mohit Mehtani; Ighovie F Onojafe; Yuri V Sergeev; Elangovan Boobalan; Marypat Jones; Ke Tang; Haiquan Liu; Chun-Hong Xia; Xiaohua Gong; Brian P Brooks
Journal:  PLoS Genet       Date:  2010-03-05       Impact factor: 5.917

9.  The emerging role of genomics in the diagnosis and workup of congenital urinary tract defects: a novel deletion syndrome on chromosome 3q13.31-22.1.

Authors:  Anna Materna-Kiryluk; Krzysztof Kiryluk; Katelyn E Burgess; Arkadiusz Bieleninik; Simone Sanna-Cherchi; Ali G Gharavi; Anna Latos-Bielenska
Journal:  Pediatr Nephrol       Date:  2013-11-30       Impact factor: 3.714

10.  PAX2 expression in low malignant potential ovarian tumors and low-grade ovarian serous carcinomas.

Authors:  Celestine S Tung; Samuel C Mok; Yvonne T M Tsang; Zhifei Zu; Huijuan Song; Jinsong Liu; Michael T Deavers; Anais Malpica; Judith K Wolf; Karen H Lu; David M Gershenson; Kwong-Kwok Wong
Journal:  Mod Pathol       Date:  2009-06-12       Impact factor: 7.842

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.